Maimonides Medical Center
Clinical trials sponsored by Maimonides Medical Center, explained in plain language.
-
New ankle implant aims to get patients walking weeks sooner
Disease control Recruiting nowThis study tests a new surgical implant called Fibulink for repairing ankle fractures with torn ligaments. The goal is to see if it allows patients to start walking fully at 4 weeks instead of the usual 6 weeks, without the implant failing. 56 adults with specific ankle injuries …
Phase: NA • Sponsor: Maimonides Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Which biopsy tool wins? study tests two devices for uterine cancer detection
Diagnosis Recruiting nowThis study compares two standard tools used to take a small tissue sample from the lining of the uterus (endometrial biopsy). The goal is to see which device works better at getting a good sample for diagnosing conditions like endometrial cancer. About 124 women aged 18 to 95 who…
Phase: PHASE4 • Sponsor: Maimonides Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Testosterone cream may stop repeat UTIs in older women
Prevention Recruiting nowThis study tests whether a vaginal testosterone cream can prevent repeat urinary tract infections (UTIs) in postmenopausal women aged 60-90 who have had at least three UTIs. Participants will apply the cream or a placebo for 9 months and be monitored for infections. The goal is t…
Phase: PHASE4 • Sponsor: Maimonides Medical Center • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
Can a light box beat daytime sleepiness in Prader-Willi?
Symptom relief Recruiting nowThis study tests whether bright light therapy can help reduce excessive daytime sleepiness in people with Prader-Willi syndrome. About 50 participants will receive either bright light or a dim placebo light. The goal is to see if the therapy improves alertness, mood, and behavior…
Phase: NA • Sponsor: Maimonides Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
One pill to stop breast pain after pregnancy loss? new trial tests cabergoline
Symptom relief Recruiting nowThis phase 2 trial tests whether a single dose of cabergoline can prevent breast engorgement, milk leakage, and tenderness after abortion or pregnancy loss at 12-18 weeks. About 348 participants will receive either cabergoline or a placebo right after the procedure and report sym…
Phase: PHASE2 • Sponsor: Maimonides Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC